The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Depressed Bronchoalveolar Urokinase Activity in Patients with Adult Respiratory Distress Syndrome
Open accessAbstract
Abundant deposition of bronchoalveolar fibrin and fibronectin occurs during the exudative phase of the adult respiratory distress syndrome (ARDS), promoting hyaline-membrane formation and subsequent alveolar fibrosis. To explore the mechanisms that account for the persistence of bronchoalveolar fibrin and fibronectin, we compared the activity of urokinase, which is necessary for plasminogen activation and fibrin degradation, in cell-free bronchoalveolar-lavage fluid from 8 patients with ARDS, 9 patients with acute pulmonary diseases other than ARDS, and 10 normal subjects. The mean level of urokinase activity in the lavage fluid from the patients with ARDS was 0.003 IU per milliliter of fluid (range, 0 to 0.008), which was significantly lower (P = 0.001) than the level in the fluid from either the patients with pulmonary diseases other than ARDS (0.118 IU per milliliter [range, 0.032 to 0.295]) or the normal subjects (0.129 IU per milliliter [range, 0.045 to 0.198]). The lavage fluid from all the patients with ARDS also had antiplasmin activity, which would promote the persistence of fibrin. A true decrease in urokinase activity was confirmed by the failure of the lavage fluid from the patients with ARDS to convert [125I]plasminogen to plasmin. Despite the low urokinase activity, immunochemical assays revealed normal levels of urokinase antigen in the fluid from the patients with ARDS, suggesting the presence of urokinase inhibitors. Inhibitors were demonstrated directly by a fibrin gel-underlay assay that detects complexes of urokinase with inhibitors. Plasminogen-activator inhibitor type 1 was the principal inhibitor identified. We conclude that increased antifibrinolytic activity due to both urokinase inhibitors and antiplasmins in the bronchoalveolar compartment of patients with ARDS contributes to the formation and persistence of hyaline membranes, a key component of alveolar histopathology in ARDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
A study of proteases and protease-inhibitor complexes in biological fluids
Granelli-Piperno, A., & Reich, E. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.1.223 · Cited by 803
Bachofen, M., & Weibel, E. R. (1977) · American Review of Respiratory Disease · doi:10.1164/arrd.1977.116.4.589 · Cited by 553
Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
Chmielewska, J., Rånby, M., & Wiman, B. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90407-3 · Cited by 469
Hallman, M., Spragg, R., Harrell, J. H., Moser, K. M., & Gluck, L. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110662 · Cited by 464
Vassalli, J. D., Dayer, J. M., Wohlwend, A., & Belin, D. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.6.1653 · Cited by 401
Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
Erickson, L. A., Ginsberg, M. H., & Loskutoff, D. J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111559 · Cited by 356
Grinnell, F., Feld, M., & Minter, D. (1980) · Cell · doi:10.1016/0092-8674(80)90526-7 · Cited by 353
Cited by
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Oddo, M., Schaller, M.-D., Feihl, F., Ribordy, V., & Liaudet, L. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000221922.08878.49 · Cited by 593
Identification of the urokinase receptor as an adhesion receptor for vitronectin.
Wei, Y., Waltz, D. A., Rao, N., Drummond, R. J., Rosenberg, S., & Chapman, H. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31646-6 · Cited by 581
Self-citationEitzman, D. T., McCoy, R. D., Zheng, X., Fay, W. P., Shen, T., Ginsburg, D., & Simon, R. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118396 · Cited by 558
Pathophysiology of Acute Lung Injury and the Acute Respiratory Distress Syndrome
Ware, L. (2006) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2006-948288 · Cited by 493
Metadata
- Authors
- Bertozzi, P., Astedt, B., Zenzius, L., Lynch, K., LeMaire, F., Zapol, W., & Chapman, H. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-03-29
- Volume
- 322
- Issue
- 13
- Pages
- 890-897
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1988996360
- Cited by
- 268
- References
- 17
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depressed Bronchoalveolar Urokinase Activity in Patients with Adult Respiratory Distress Syndrome. https://app.cochat.ai/papers/10.1056/nejm199003293221304
- The paper
- Bertozzi, P., Astedt, B., Zenzius, L., Lynch, K., LeMaire, F., Zapol, W., & Chapman, H. A. (1990). Depressed Bronchoalveolar Urokinase Activity in Patients with Adult Respiratory Distress Syndrome. New England Journal of Medicine. https://doi.org/10.1056/nejm199003293221304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.